Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profileg
Sia Daneshmand, M.D.

@siadaneshmand

Professor of Urology and Oncology (Clinical Scholar)
Director of Urologic Oncology
Director of Clinical Research
Urologic Oncology Fellowship Director
USC

ID:49533860

calendar_today22-06-2009 04:17:54

707 Tweets

3,2K Followers

587 Following

Simon Kim, MD, MPH(@simon_p_kim) 's Twitter Profile Photo

This is a fantastic opportunity for medical students interested in urology! A great chance to meet with some awesome leaders and people and do some pretty cool research.

account_circle
Journal of Clinical Oncology(@JCO_ASCO) 's Twitter Profile Photo

๐Ÿ™Œ Enfortumab vedotin + pembro as 1st-line tx for metastatic yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo.ย ๐Ÿ‘‰ fal.cn/3sEjU Jonathan Rosenberg MD

๐Ÿ™Œ Enfortumab vedotin + pembro as 1st-line tx for metastatic #UrothelialCancer yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo.ย ๐Ÿ‘‰ fal.cn/3sEjU #JCO #blcsm #kcsm #gucsm @DrRosenbergMSK
account_circle
Carolyn Meltzer, MD(@DeanMeltzer) 's Twitter Profile Photo

We fully join President Folt in our support of, and admiration for the brave Iranian women and men who continue to risk their lives for basic rights. Freedom, dignity, and respect are human rights.

Dean Carolyn Meltzer and SVP Steven Shapiro

account_circle
Morteza Dehghani(@MortezDehghani) 's Twitter Profile Photo

Iranian academics are under attack. We call on all academics to defend faculty and students in Iran, and demand the immediate release of all students from the prisons of the regime.

My academic colleagues, I expect all of you to sign this statement.

SupportIranianAcademics.org

Iranian academics are under attack. We call on all academics to defend faculty and students in Iran, and demand the immediate release of all students from the prisons of the regime. My academic colleagues, I expect all of you to sign this statement. SupportIranianAcademics.org
account_circle
Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo

Indeed well done trial. ๐Ÿ‘ Several caveats to consider: #1 Vast majority IR highlighted by Saum Ghodoussipour #2 low CIS (11-13%) where BL best. #3 wide CI 0.69-1.28 #4 BL performed once at start. RFS curves in favor of BL up to 12-15 mos. Would RFS have diverged if f/u also done with BL?

Indeed well done trial. ๐Ÿ‘ Several caveats to consider: #1 Vast majority IR highlighted by @saumyg #2 low CIS (11-13%) where BL best. #3 wide CI 0.69-1.28 #4 BL performed once at start. RFS curves in favor of BL up to 12-15 mos. Would RFS have diverged if f/u also done with BL?
account_circle
Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo

Oldies but goodies. Stephen Boorjian, MD Mayo Clinic Urology USC series ncbi.nlm.nih.gov/pubmed/15538242 Mayo series. ncbi.nlm.nih.gov/pubmed/17631342 Some with limited nodes can be cured. We still see them in clinic!

Oldies but goodies. @SBoorjian @MayoUrology USC series ncbi.nlm.nih.gov/pubmed/15538242 Mayo series. ncbi.nlm.nih.gov/pubmed/17631342 Some with limited nodes can be cured. We still see them in clinic!
account_circle
Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo

Agree with esteemed colleagues. If intraperitoneal but recognized immediately and case aborted is ex lap or drain mandatory? Perhaps some can be managed conservatively as well.

account_circle
Bernie Bochner, MD(@bbmdmsk) 's Twitter Profile Photo

DrBagrodia Sam S. Chang MD, MBA Sia Daneshmand, M.D. Anne Schuckman Amir Salmasi Eugene Pietzak Solomon Woldu Jay B. Shah Angie Smith Agree with DrBagrodia If extraperitoneal, just a cath until healed (confirm with cystogram). If resection was incomplete, go back and finish resection once healing is complete.

I donโ€™t keep them abx just cover when the cath is removed.

account_circle
Shilpa Gupta(@shilpaonc) 's Twitter Profile Photo

Sumanta Pal Uromigos ๐Ÿ’™alison birtle Tom Powles Neeraj Agarwal Brian Rini, MD Sia Daneshmand, M.D. Vadim Koshkin MD Very interesting indeed! An unmet need to do novel biomarker-driven adjuvant trials like PROOF-302 trial exploring the role of FGFR inhibition in pts with FGFR3 alterations.

clinicaltrials.gov/ct2/show/NCT04โ€ฆ

account_circle
Paul Sargos(@PaulSargos) 's Twitter Profile Photo

Really to proud to be a speaker at the first meeting in Bangalore, , next week.
๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ
Unfortunately, Virtual ๐Ÿ™.

๐Ÿ”Š๐Ÿ”ŠGreat expert panel Vedang Murthy Amar Kishan Sia Daneshmand, M.D. Prof Ananya๐Ÿ’™

โœŒ๏ธThanks a lot Vedang Murthy for this invitation.

Really to proud to be a speaker at the first #sogocon meeting in Bangalore, #india, next week. ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฎ๐Ÿ‡ณ Unfortunately, Virtual ๐Ÿ™. ๐Ÿ”Š๐Ÿ”ŠGreat expert panel @VedangMurthy @AmarUKishan @siadaneshmand @achoud72 โœŒ๏ธThanks a lot @VedangMurthy for this invitation.
account_circle
Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo

Agree w many points my esteemed colleagues brought up. I don't see it as a 'versus' issue & the era of comparisons nearing the end. Diff operations require diff tools and surgeon skills. We should adapt to meet our patient needs. Many complex issues still require open skill set.

account_circle
Bernie Bochner, MD(@bbmdmsk) 's Twitter Profile Photo

I primarily train fellows (grads of very good residencyโ€™s) and in no way have we noticed that the robot has led to better overall surgical competencies. Robotic skills are better developed compared to open due to reps. IMHO however overall competency has not been improved.

account_circle